Glenmark Pharmaceuticals Limited (GLENMARK.NS)
INR 1541.1
(1.08%)
INR 1541.1
(1.08%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 46.95 Billion INR | -48.84% |
| 2022 | 65.21 Billion INR | 11.01% |
| 2021 | 58.74 Billion INR | 9.88% |
| 2020 | 53.46 Billion INR | -0.04% |
| 2019 | 53.48 Billion INR | 1.72% |
| 2018 | 52.58 Billion INR | 15.04% |
| 2017 | 45.7 Billion INR | -3.65% |
| 2016 | 47.43 Billion INR | 19.86% |
| 2015 | 39.57 Billion INR | 8.83% |
| 2014 | 36.36 Billion INR | 16.27% |
| 2013 | 31.27 Billion INR | 26.34% |
| 2012 | 24.75 Billion INR | 20.8% |
| 2011 | 20.49 Billion INR | 55.37% |
| 2010 | 13.19 Billion INR | 41.33% |
| 2009 | 9.33 Billion INR | 30.61% |
| 2008 | 7.14 Billion INR | 27.9% |
| 2007 | 5.58 Billion INR | 41.69% |
| 2006 | 3.94 Billion INR | 58.33% |
| 2005 | 2.49 Billion INR | 27.06% |
| 2004 | 1.96 Billion INR | 40.16% |
| 2003 | 1.39 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.35 Billion INR | -3.09% |
| 2023 Q4 | 8.62 Billion INR | -51.67% |
| 2023 Q1 | 16.31 Billion INR | -1.12% |
| 2023 Q2 | 16.42 Billion INR | 0.64% |
| 2023 Q3 | 17.83 Billion INR | 8.63% |
| 2023 FY | 33.36 Billion INR | -48.84% |
| 2022 FY | 65.21 Billion INR | 11.01% |
| 2022 Q4 | 16.5 Billion INR | -6.68% |
| 2022 Q1 | 14.23 Billion INR | -6.21% |
| 2022 Q2 | 16.79 Billion INR | 18.04% |
| 2022 Q3 | 17.68 Billion INR | 5.26% |
| 2021 Q4 | 15.17 Billion INR | 1.48% |
| 2021 Q1 | 13.46 Billion INR | -0.9% |
| 2021 Q2 | 15.14 Billion INR | 12.49% |
| 2021 FY | 58.74 Billion INR | 9.88% |
| 2021 Q3 | 14.95 Billion INR | -1.29% |
| 2020 Q4 | 13.58 Billion INR | -5.13% |
| 2020 Q3 | 14.32 Billion INR | 0.98% |
| 2020 Q1 | 11.36 Billion INR | -14.36% |
| 2020 FY | 53.46 Billion INR | -0.04% |
| 2020 Q2 | 14.18 Billion INR | 24.87% |
| 2019 Q1 | 12.22 Billion INR | -19.64% |
| 2019 Q3 | 13.78 Billion INR | -3.03% |
| 2019 Q2 | 14.21 Billion INR | 16.28% |
| 2019 FY | 53.48 Billion INR | 1.72% |
| 2019 Q4 | 13.26 Billion INR | -3.74% |
| 2018 Q4 | 15.21 Billion INR | 16.42% |
| 2018 FY | 52.58 Billion INR | 15.04% |
| 2018 Q3 | 13.06 Billion INR | -0.43% |
| 2018 Q2 | 13.12 Billion INR | 18.97% |
| 2018 Q1 | 11.03 Billion INR | -4.65% |
| 2017 Q4 | 11.56 Billion INR | -4.56% |
| 2017 Q2 | 11.74 Billion INR | 3.35% |
| 2017 FY | 45.7 Billion INR | -3.65% |
| 2017 Q1 | 11.36 Billion INR | -17.17% |
| 2017 Q3 | 12.12 Billion INR | 3.19% |
| 2016 Q4 | 13.72 Billion INR | 11.09% |
| 2016 Q3 | 12.35 Billion INR | -0.34% |
| 2016 Q2 | 12.39 Billion INR | 31.75% |
| 2016 Q1 | 9.4 Billion INR | -29.67% |
| 2016 FY | 47.43 Billion INR | 19.86% |
| 2015 Q3 | 9.4 Billion INR | -3.85% |
| 2015 FY | 39.57 Billion INR | 8.83% |
| 2015 Q1 | 8.47 Billion INR | -28.01% |
| 2015 Q2 | 9.78 Billion INR | 15.52% |
| 2015 Q4 | 13.37 Billion INR | 42.16% |
| 2014 Q2 | 8.6 Billion INR | 13.31% |
| 2014 Q4 | 11.76 Billion INR | 24.79% |
| 2014 FY | 36.36 Billion INR | 16.27% |
| 2014 Q3 | 9.42 Billion INR | 9.65% |
| 2014 Q1 | 7.59 Billion INR | -27.53% |
| 2013 Q3 | 7.55 Billion INR | 6.71% |
| 2013 FY | 31.27 Billion INR | 26.34% |
| 2013 Q4 | 10.47 Billion INR | 38.64% |
| 2013 Q1 | 6.17 Billion INR | -17.87% |
| 2013 Q2 | 7.07 Billion INR | 14.74% |
| 2012 FY | 24.75 Billion INR | 20.8% |
| 2012 Q4 | 7.51 Billion INR | 20.42% |
| 2012 Q2 | 5.67 Billion INR | 6.19% |
| 2012 Q1 | 5.34 Billion INR | -10.93% |
| 2012 Q3 | 6.23 Billion INR | 9.99% |
| 2011 Q3 | 5.7 Billion INR | 0.0% |
| 2011 Q4 | 5.99 Billion INR | 5.14% |
| 2011 FY | 20.49 Billion INR | 55.37% |
| 2010 FY | 13.19 Billion INR | 41.33% |
| 2009 FY | 9.33 Billion INR | 30.61% |
| 2008 FY | 7.14 Billion INR | 27.9% |
| 2007 FY | 5.58 Billion INR | 41.69% |
| 2006 FY | 3.94 Billion INR | 58.33% |
| 2005 FY | 2.49 Billion INR | 27.06% |
| 2004 FY | 1.96 Billion INR | 40.16% |
| 2003 FY | 1.39 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sigachi Industries Limited | 579.88 Million INR | -7996.846% |
| Ind-Swift Limited | 946.56 Million INR | -4860.3% |
| Bajaj HealthCare Limited | 985.34 Million INR | -4665.088% |
| Sakar Healthcare Limited | 204.07 Million INR | -22907.051% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 15.641% |
| Innova Captab Limited | 931.03 Million INR | -4943.077% |
| Divi's Laboratories Limited | 14.17 Billion INR | -231.352% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -1798.224% |
| Morepen Laboratories Limited | 1.98 Billion INR | -2262.452% |
| Mankind Pharma Limited | 29.27 Billion INR | -60.396% |
| Sequent Scientific Limited | 2.9 Billion INR | -1518.044% |
| Wanbury Limited | 978.96 Million INR | -4696.138% |
| Laurus Labs Limited | 11.9 Billion INR | -294.235% |
| Nectar Lifesciences Limited | 932.7 Million INR | -4934.047% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -303.349% |
| Alembic Limited | 872.45 Million INR | -5281.641% |
| Hikal Limited | 4.46 Billion INR | -951.852% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -195.863% |
| Neuland Laboratories Limited | 2.92 Billion INR | -1502.615% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | -217.407% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -2033.238% |
| Themis Medicare Limited | 1.12 Billion INR | -4070.603% |
| RPG Life Sciences Limited | 1.63 Billion INR | -2770.838% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 62.501% |
| Lupin Limited | 125.09 Billion INR | 62.467% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -2142.203% |
| Wockhardt Limited | 8.48 Billion INR | -453.686% |
| Vaishali Pharma Limited | 84.02 Million INR | -55776.614% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -1427.211% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -10606.319% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -224.841% |
| FDC Limited | 3.49 Billion INR | -1241.594% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 51.029% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -11284.453% |
| Eris Lifesciences Limited | 4.94 Billion INR | -849.891% |
| Venus Remedies Limited | 1.91 Billion INR | -2350.188% |
| ZIM Laboratories Limited | 1.01 Billion INR | -4534.736% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -3208.331% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -80452.678% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -2059.235% |
| Shilpa Medicare Limited | 3.33 Billion INR | -1308.22% |
| Albert David Limited | 1.02 Billion INR | -4475.617% |
| Ajanta Pharma Limited | 30.46 Billion INR | -54.131% |
| Hester Biosciences Limited | 908.84 Million INR | -5066.207% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -3247.086% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -1738.321% |
| Gufic Biosciences Limited | 1.18 Billion INR | -3856.935% |
| Windlas Biotech Limited | 1 Billion INR | -4564.888% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -1467.489% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -330249.398% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -28842.328% |
| Granules India Limited | 10.31 Billion INR | -355.284% |
| Aarti Drugs Limited | 1.16 Billion INR | -3921.705% |
| Bal Pharma Limited | 555.62 Million INR | -8350.389% |
| Alkem Laboratories Limited | 32.83 Billion INR | -42.995% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 69.547% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -4270.99% |
| Medicamen Biotech Limited | 335.16 Million INR | -13908.706% |
| Unichem Laboratories Limited | 6.72 Billion INR | -598.089% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -10205.993% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -688353.959% |
| Valiant Laboratories Limited | 138.02 Million INR | -33916.446% |
| Orchid Pharma Limited | 800.77 Million INR | -5763.419% |
| Medico Remedies Limited | 59.67 Million INR | -78580.452% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -2110.381% |
| Ipca Laboratories Limited | 18.98 Billion INR | -147.28% |
| Brooks Laboratories Limited | 51.18 Million INR | -91640.055% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -13484.513% |
| Piramal Enterprises Limited | 63.65 Billion INR | 26.236% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -119.178% |
| NATCO Pharma Limited | 10.05 Billion INR | -366.818% |
| Suven Life Sciences Limited | 109.75 Million INR | -42681.376% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -101625.799% |
| Strides Pharma Science Limited | 9.16 Billion INR | -412.454% |
| Indoco Remedies Limited | 12.06 Billion INR | -289.286% |
| Alpa Laboratories Limited | 127.38 Million INR | -36760.229% |
| Lasa Supergenerics Limited | 291.17 Million INR | -16025.258% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -1426.019% |